4.7 Article

Ferrocenyl and dicobalt hexacarbonyl chromones - New organometallics inducing oxidative stress and arresting human cancer cells in G2/M phase

Journal

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 81, Issue -, Pages 289-300

Publisher

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2014.05.023

Keywords

Anticancer activity; Ferrocene; ROS; Apoptosis; Cell cycle; Chromone

Funding

  1. National Science Centre in Cracow, Poland [DEC-2011/03/B/ST5/01015]

Ask authors/readers for more resources

The straightforward syntheses of four new ferrocenyl and dicobalt hexacarbonyl chromones are presented. The redox behavior of the novel metallo-chromones has been examined by cyclic voltammetry (CV), revealing a reversible behavior of the ferrocenyl groups, while the dicobalt hexacarbonyl derivatives show irreversible oxidation. The anticancer activity of the products has been evaluated against hepatocellular carcinoma (Hep G2), ER+ (MCF-7) and ER (MDA-MB-231) breast adenocarcinoma, and leukemic (CCRF-CEM) human cancer cell lines. The mechanism of action for the most active complexes has been investigated and it seems to involve oxidative stress and apoptosis induction. Moreover, the results show that the investigated metallo-chromones generate damage to DNA and arrest the cell cycle in G2/M phase. (C) 2014 Elsevier Masson SAS. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available